EASL recommends that, in the correct context, a diagnosis of AMA-negative PBC can be made in patients with cholestasis and ANA-specific immuno-fluorescence (nuclear dots or perinuclear rims) or ELISA (using sp100 or gp210 antibodies) [51,65]. The gene discussed is NUP210; the disease is cholestasis.